Orexigen Therapeutics, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012

Published: Mar 14, 2013

SAN DIEGO, March 13, 2013 -- /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the fourth quarter and year ended December 31, 2012.

Back to news